Parkman Healthcare Partners LLC Ani Pharmaceuticals Inc Transaction History

Parkman Healthcare Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$50.28 - $64.61 $3.15 Million - $4.05 Million	-62,675 Reduced 35.92%	111,802 $6.49 Million
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $2.78 Million - $4.01 Million	74,477 Added 74.48%	174,477 $9.39 Million
Q1 2023 May 12, 2023	SELL	$37.61 - $45.72 $1.01 Million - $1.23 Million	-26,874 Reduced 21.18%	100,000 $3.97 Million
Q4 2022 Feb 13, 2023	BUY	$31.9 - $41.95 $284,962 - $374,739	8,933 Added 7.57%	126,874 $5.1 Million
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $279,865 - $356,609	9,382 Added 8.64%	117,941 $3.79 Million
Q2 2022 Aug 12, 2022	BUY	$23.09 - $33.46 $14,962 - $21,682	648 Added 0.6%	108,559 $3.22 Million
Q1 2022 May 13, 2022	SELL	$26.91 - $47.15 $788,866 - $1.38 Million	-29,315 Reduced 21.36%	107,911 $3.03 Million
Q4 2021 Feb 11, 2022	BUY	$32.97 - $56.85 $1.71 Million - $2.95 Million	51,880 Added 60.79%	137,226 $6.32 Million
Q3 2021 Nov 12, 2021	BUY	$26.48 - $35.99 $794,400 - $1.08 Million	30,000 Added 54.2%	85,346 $2.8 Million
Q2 2021 Aug 13, 2021	BUY	$31.86 - $38.6 $1.76 Million - $2.14 Million	55,346 New	55,346 $1.94 Million

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.